Lataa...
Methotrexate decreases tenofovir exposure in antiretroviral-suppressed individuals living with HIV
BACKGROUND: To mitigate increased risk of premature cardiovascular disease in antiretroviral therapy (ART) suppressed adults living with HIV (PWH), low dose methotrexate (LDMTX) was evaluated in a multicenter randomized placebo controlled clinical trial of 176 PWH taking various ART regimens (ACTG A...
Tallennettuna:
| Julkaisussa: | J Acquir Immune Defic Syndr |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8132144/ https://ncbi.nlm.nih.gov/pubmed/33177476 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000002502 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|